Advertisement

Document › Details
Ascenion GmbH. (8/9/23). "Press Release: Ascenion Supports HZI Spin-off Leopard Biosciences".
![]() |
Organisation | Ascenion GmbH |
Group | Life Science-Stiftung (LifeScience Foundation) (Group) | |
Organisation 2 | Leopard Biosciences GmbH | |
![]() |
Product | CRISPR-based diagnostic |
Product 2 | diagnostic test, rapid (point-of-care) | |
![]() |
Person | Beisel, Chase (Leopard Biosciences 202308 Managing Director + Co-Founder) |
Person 2 | Zollner, Stanislava (Helmholtz 202008 at Ascenion GmbH) | |
Leopard Biosciences GmbH, founded in July, is developing a new diagnostic platform that can detect multiple markers in a single test. The translation of the technology was made possible by funding from the Helmholtz Association.
The innovative CRISPR/Cas-based diagnostic platform LEOPARD was developed in a collaboration between the Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for Infection Research (HZI) in Würzburg, and the Julius-Maximilians-Universität of Würzburg (JMU). It enables the detection of multiple RNA and DNA biomarkers in a simple point-of-care test, allowing better and faster treatment decisions. The ease of use of the tests holds great potential for application in settings without access to clinical laboratory infrastructure. The technology can be used in the field of infectious diseases and many other application areas, e.g. cancer or genetic diseases.
For the company foundation, the research department "Synthetic RNA Biology" at HIRI received funding totalling more than 1 million Euros from the spin-off program Helmholtz Enterprise and the Helmholtz Transfer Campaign. "The foundation enables us to seek additional investors in order to develop products on the LEOPARD platform and to advance their commercialization," said Chase Beisel, research department leader at HIRI as well as professor at JMU and now also Managing Director of the newly founded Leopard Biosciences GmbH. The team is completed by Dr Mikkel Noerholm, Managing Director, and Dr Constantinos Patinios, Senior Scientist.
As a technology transfer partner of the HZI and HIRI, Ascenion has been working closely with the scientists for many years, supporting the protection of intellectual property, the acquisition of funding and the establishment of cooperations for further development. Together with the technology transfer department of the HZI, Ascenion accompanied the entire start-up phase and acquired shares in LEOPARD Biosciences GmbH. Ascenion and HZI technology transfer will actively continue to accompany Leopard Biosciences GmbH.
Revenues Ascenion may receive from a potential future exit will be largely distributed to the LifeScience Foundation, which in turn provides them as research grants to the endowing institutions, including the HZI.
Contact
Communication & Event Management
Stanislava Zollner
T: +49 89 318814-14
[email protected]
Record changed: 2024-04-04 |
Advertisement

More documents for Life Science-Stiftung (LifeScience Foundation) (Group)
- [1] Pantherna Therapeutics GmbH. (5/3/24). "Press Release: Company Update. Ansgar Santel Appointed as New CEO". Frankfurt a. M. & Hennigsdorf....
- [2] Praque.bio, z.s.. (3/11/24). "Press Release: This Fall Prague Will Be the Stage for a Showcase of Cutting-edge Biotechnologies Featuring Prominent Figures such as Christian A. Stein, Petr Jansa, and other Leading Experts". Prague....
- [3] Ascenion GmbH. (6/21/22). "Press Release: Carma Fund I Completes First Closing of EUR 47 Million to Accelerate the Transfer of Life-Science Research into Practice". Munich & Frankfurt a. M.....
- [4] Provirex Genome Editing Therapies GmbH. (4/29/20). "Press Release: Start-Up Provirex – Innovative Approach to Curing HIV Infection. Ascenion and Innovationsstarter Fonds Hamburg Acquire Equity in Hamburg Start-up". Munich....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top